ASCO: Trabectedin Useful in Recurrent Ovarian Cancer

posted on Jun 08 by in the Uncategorized category CHICAGO (MedPage Today) -- Trabectedin may have a role in the treatment of recurrent ovarian cancer while sparing patients for a time from platinum-based regimens, according to several studies presented here.

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes